Owl Tree Therapy - Speech-Language Pathologist in Loveland, CO

Owl Tree Therapy is a Speech-language Pathologist based in Loveland, Colorado. Owl Tree Therapy is licensed to practice in * (Not Available) (license number ) and their current practice location is 365 E 41st Ct, Loveland, Colorado. It can be reached at their office (for appointments etc.) via phone at (970) 231-0744.

NPI number for Owl Tree Therapy is 1053758151 and their current mailing address is 365 E 41st Ct, Loveland, Colorado. Owl Tree Therapy does not participate in medicare program and thus does not accept medicare assignments. The facility's NPI Number is 1053758151.

Contact Information

Owl Tree Therapy
365 E 41st Ct,
Loveland, CO 80538-4815
(970) 231-0744
Not Available



Healthcare Provider's Profile

Full NameOwl Tree Therapy
TypeFacility
SpecialitySpeech-language Pathologist
Location365 E 41st Ct, Loveland, Colorado
Accepts Medicare AssignmentsDoes not participate in Medicare Program. The facility may not accept medicare assignment.
  NPI Data:
  • NPI Number: 1053758151
  • Provider Enumeration Date: 05/29/2013
  • Last Update Date: 05/29/2013

Medical Identifiers

Medical identifiers for Owl Tree Therapy such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1053758151NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
235Z00000XSpeech-language Pathologist (* (Not Available))Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Owl Tree Therapy is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Owl Tree Therapy
365 E 41st Ct,
Loveland, CO 80538-4815

Ph: () -
Owl Tree Therapy
365 E 41st Ct,
Loveland, CO 80538-4815

Ph: (970) 231-0744

News Archive

Exercise alone without creatine supplements helps in cardiac rehabilitation

Athletes have been enjoying the benefits of creatine supplements to gain stronger muscles since the 1990s, and the supplement has also proven beneficial among other groups. Could it help cardiac patients regain strength to help with their heart-training workouts as part of rehabilitation? The evidence at this stage suggests not - exercise alone proved a far more powerful tonic for patients in a study out today. The results appear in the journal Clinical Rehabilitation, published by SAGE.

Childhood coagulation marker levels distinct from adulthood

Levels of key coagulation markers significantly vary with age in children, research reveals, potentially affecting the diagnosis and treatment of pediatric thrombotic and hemorrhagic disease.

Study reveals conclusive results in reducing toxicities for Asian patients with mRCC

A study led by the Genitourinary (GU) oncology team at National Cancer Centre Singapore has revealed conclusive results in reducing toxicities for Asian patients with metastatic renal cell carcinoma (mRCC) or cancer that has spread beyond the kidney.

New HIS guidelines to minimise surgical infection in day centres and primary care

New guidelines from the Healthcare Infection Society (HIS) aimed at minimising surgical infection in day centres and primary care are now published in The Journal of Hospital Infection .

Prism Pharmaceuticals to be acquired by Baxter

Ligand Pharmaceuticals Incorporated announced that its partner Prism Pharmaceuticals has entered into a definitive agreement to be acquired by Baxter International Inc.. Prism Pharmaceuticals recently received FDA approval for Nexterone®, an antiarrhythmic agent which Ligand (through its CyDex Pharmaceuticals subsidiary) originally developed with its patented Captisol® formulation technology and licensed to Prism in 2006.

Read more News

› Verified 7 days ago


Speech-Language Pathologist in Loveland, CO

Mrs. Nancy J Barron, MS, CCC-S
Speech-Language Pathologist
Medicare: Medicare Enrolled
Practice Location: 4976 Filbert Dr, Loveland, CO 80538
Phone: 970-669-4019    
Mrs. Fawn Gold, M.A., CCC-SLP
Speech-Language Pathologist
Medicare: Not Enrolled in Medicare
Practice Location: 5798 Aspen View Pl, Loveland, CO 80538
Phone: 970-405-9230    Fax: 970-688-4181
Adam Headlee, MA, CCC-SLP
Speech-Language Pathologist
Medicare: Not Enrolled in Medicare
Practice Location: 2139 S Custer Ave, Loveland, CO 80537
Phone: 970-232-4274    
Holly K Ambrozi, SLP
Speech-Language Pathologist
Medicare: Medicare Enrolled
Practice Location: 2643 Sapphire St, Loveland, CO 80537
Phone: 720-477-0294    
Thompson School District
Speech-Language Pathologist
Medicare: Not Enrolled in Medicare
Practice Location: 800 S Taft Ave, Loveland, CO 80537
Phone: 970-613-5000    
Aspen Speech Therapy And Rehabilitation Llc
Speech-Language Pathologist
Medicare: Not Enrolled in Medicare
Practice Location: 2114 N Lincoln Ave Ste 102, Loveland, CO 80538
Phone: 970-682-3743    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.